EU CHMP recommends TRYNGOLZA approval for severe hypertriglyceridemia
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended TRYNGOLZA (olezarsen) for approval in the EU for severe hypertriglyceridemia.
Story updates
10:45:31 AM UTC
SquawkNews
CHMP issued a positive opinion recommending EU approval of TRYNGOLZA (olezarsen) for adults with sHTG (≥880 mg/dL), ahead of schedule. A final European Commission decision is expected in Q4 2026.Material DetailsContext by AI AnalystThis is a late-stage regulatory milestone building on prior U.S. ap…